Asston Pharmaceuticals Limited (BOM:544445)

India flag India · Delayed Price · Currency is INR
78.00
-2.50 (-3.11%)
At close: Mar 9, 2026
-34.45%
Market Cap 664.01M
Revenue (ttm) 244.84M
Net Income (ttm) 24.58M
Shares Out 8.51M
EPS (ttm) 3.76
PE Ratio 20.74
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 4,000
Average Volume 6,800
Open 78.00
Previous Close 80.50
Day's Range 78.00 - 78.00
52-Week Range 75.21 - 126.00
Beta n/a
RSI 51.01
Earnings Date Feb 13, 2026

About Asston Pharmaceuticals

Asston Pharmaceuticals Limited manufactures pharmaceutical products in India, West Africa, South Africa, and Asian countries. The company provides tablets, such as aceclofenac, albendazole, aminophylline, artemether and lumefantrine, ascorbic acid chewable, azithromycin, b-complex, calcium, cholecalciferol with folic acid, cefixime, cetirizine, ciprofloxacin, co-trimoxazole, cyproheptadine, dexamethasone, diclofenac, ferrous sulphate, folic acid, glucose, griseofulvin, levofloxacin, loperamide HCL, losartan potassium, mebendazole, metformin hyd... [Read more]

Industry Pharmaceutical Preparations
Founded 2019
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 544445
Full Company Profile

Financial Performance

In fiscal year 2025, Asston Pharmaceuticals's revenue was 250.39 million, an increase of 60.65% compared to the previous year's 155.86 million. Earnings were 43.25 million, an increase of 217.95%.

Financial Statements

News

There is no news available yet.